KCNK3 and pulmonary hypertension: These gene expression differences in iPS-derived mesenchymal cells suggested that KCNK3 mutation may predispose to pulmonary hypertension through mechanisms previously associated with PAH, including vascular tone, metabolism, or inflammation.